According to Relmada Therapeutics's latest financial reports the company's current earnings (TTM) are -ยฃ66.12 M. In 2023 the company made an earning of -ยฃ75.28 M an increase over its 2022 earnings that were of -ยฃ0.12 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.